The confirmed new prices for 01
Apr as part of the expanded and
accelerated price disclosure main
cycle have been published on the
Pharmaceutical Benefits Scheme
(PBS) website.
The biggest cut was to docetaxel
injection, which saw an almost 90%
cut (PD 17 Dec).
The confirmed prices show this
was a reduction from an approved
ex-manufacturer price of $479.17
down to $48.11 (Oncotaxel 140).
Another significant price cut was
topotecan, down by 56%, from
$330.40 to $145.77.
Fludrabine injection was cut by
48% which the published prices
show was down from $103.11 to
$53.87.
To view the confirmed prices,
CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 12 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Mar 14
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.